Navigation Links
Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
Date:9/3/2007

Inclusion of Gerresheimer Stock in the SDAX as Per September 6, 2007

Outside the Normal Schedule Decision on Possible Inclusion in the MDAX to be Taken on 5 September

DÜSSELDORF, Germany, September 3 /PRNewswire/ -- Gerresheimer AG has been listed in the Prime Standard of the Frankfurter Stock exchange since June 11, 2007, following one of the largest IPOs of the year, with a total issue volume of more than 900 million euros. Gerresheimer stock will be included in the SDAX index of Deutsche Borse, Frankfurt am Main, on September 6, 2007 outside the normal schedule.

Possible inclusion of Gerresheimer stock in the MDAX index is independent of this decision. Changes in the composition of the selection indices are to be published by Deutsche Borse this coming Wednesday, 5 September.

Dr. Axel Herberg, CEO of Gerresheimer AG, in welcoming the decision, says: "We are pleased that our stock is to be included in the SDAX outside the normal schedule after only three months on the stock exchange and thereby becomes even more attractive."

Gerresheimer is a pharmaceutical & life science supply and services company with market leading positions of specialty products made of glass and plastic. Gerresheimer owns 37 production sites in Europe, North America and Asia and employs approximately 10,000 employees worldwide.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telefon +49-211-6181-250

Telefax +49-211-6181-241

e-mail b.lingenberg@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The Dangers Of Vitamin A To Pregnant Women To Be Included On Label
2. Hepatitis B Vaccine To Be Included In National Immunization Programme
3. ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included
4. Meningitis Vaccine To Be Included In Childhood Immunization Programme
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. Eight More African Countries Included In US Malaria Program
7. Yoga, to Be Included in Schools as Part of the Curriculum
8. A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List
9. Gene linked to early puberty in girls
10. Cancer drugs in development nearly doubled since 1995
11. Nearly all asthma deaths preventable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: